Together with researchers from University of Oxford, researchers at Karolinska Institutet have demonstrated that a subclass of stem cells that are dedicated to the production of platelets replenish those platelets through a distinct and shorter pathway…
Autoimmune diseases occur when the body’s immune system attacks healthy cells instead of protecting them. Systemic sclerosis (SSc) is one such autoimmune condition characterized by faulty circulatory and immune systems, leading to the occurrence of fib…
Infections acquired by patients in intensive care units (ICUs) are bad news. These patients, many on life support, are already vulnerable. An infection will increase their chance of dying.
In mid-2015 and early 2016 in Finland, a group of scientists became interested in inspecting doormats. The pursuit, while seemingly unusual, had a serious aim: to determine whether a higher mix of microbes typically found in rural environments might pr…
The quest to develop universal donor blood has taken a decisive step forward. Researchers at DTU and Lund University have discovered enzymes that, when mixed with red blood cells, are able to remove specific sugars that make up the A and B antigens in …
Severe sepsis from bacterial or viral infections can be life-threatening and even people recovering from severe sepsis may experience long-lasting effects on the immune system, making them more susceptible to recurrent infections. The causes for this s…
Researchers at EPFL reveal how Drosophila’s Turandot proteins protect against immune self-harm. The study is the first to identify some proteins that protect against antimicrobial peptides offering insights into cellular resilience mechanisms with pote…
Magnetic resonance imaging (MRI) and lumbar puncture (LP) may not always be necessary for diagnosing and managing a serious neurological complication associated with CAR T-cell therapy, according to a new Blood Advances study. Findings further validate…
A process of taking patients’ own cells and reprogramming them to fight cancer has been a last-ditch option for blood cancer patients when nothing else worked, but a new study underway in Aurora is trying to determine whether more patients could benefi…
Researchers from the UoC’s Center for Biochemistry at the Faculty of Medicine and the UoC CECAD Cluster of Excellence in Aging Research have discovered that an excessive immune response can be prevented by the intramembrane protease RHBDL4.
